0.90

24.17% 0.1752

After Hours: .90

Sutro Biopharma Inc (STRO)

Overview News Price History Option Chain Financials Discussions Forecast

Sutro Biopharma Inc stock is traded at $0.90, with a volume of 3.09M. It is up +24.17% in the last 24 hours and up +17.36% over the past month. Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Previous Close:

$0.7248

Open:

$0.74

24h Volume:

3.09M

Relative Volume:

2.02

Market Cap:

$45.24M

Revenue:

$153.73M

Net Income/Loss:

$-106.79M

P/E Ratio:

-0.5056

EPS:

-1.78

Net Cash Flow:

$-115.93M

1W Performance:

+66.67%

1M Performance:

+17.36%

6M Performance:

-74.29%

1Y Performance:

-75.81%

1-Day Range:

$0.74

$0.9005

1-Week Range:

$0.5231

$0.9005

52-Week Range:

$0.5231

$5.17

Sutro Biopharma Inc Stock (STRO) Company Profile

Name

Sutro Biopharma Inc

Sector

Healthcare (1155)

Industry

Biotechnology (679)

Phone

650-392-8412

Address

111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA

Employee

310

Twitter

@SutroBio

Next Earnings Date

2024-11-11

Latest SEC Filings

STRO's Discussions on Twitter

Compare STRO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STRO Sutro Biopharma Inc	0.90	45.24M	153.73M	-106.79M	-115.93M	-1.78
VRTX Vertex Pharmaceuticals Inc	492.42	124.91B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	587.85	60.05B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	594.65	35.88B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	241.97	29.83B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	249.13	24.58B	3.81B	-644.79M	-669.77M	-6.24

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-17-25	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-14-25	Downgrade	BofA Securities	Buy → Underperform
Mar-14-25	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Mar-14-25	Downgrade	Wedbush	Outperform → Neutral
May-08-24	Initiated	BofA Securities	Buy
Nov-09-23	Initiated	Deutsche Bank	Buy
Oct-06-23	Initiated	Oppenheimer	Outperform
Mar-21-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-18-22	Resumed	Wells Fargo	Overweight
Jun-18-21	Initiated	H.C. Wainwright	Buy
Dec-03-20	Initiated	Stifel	Buy
Sep-02-20	Initiated	Jefferies	Buy
Jul-16-20	Initiated	Wells Fargo	Overweight
Jan-13-20	Initiated	SunTrust	Buy
Oct-07-19	Initiated	BTIG Research	Buy
Jul-18-19	Initiated	Deutsche Bank	Buy
Apr-29-19	Initiated	H.C. Wainwright	Buy
Oct-22-18	Initiated	JMP Securities	Mkt Outperform
Oct-22-18	Initiated	Piper Jaffray	Overweight
Oct-22-18	Initiated	Wedbush	Outperform

View All

Sutro Biopharma Inc Stock (STRO) Latest News

Apr 23, 2025

LPL Financial LLC Has $667,000 Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 23, 2025

Apr 22, 2025